Macroporous thermosensitive poly(HEMA-coNIPAAm) hydrogels for controlled drug delivery application
Abstract
Controlled delivery systems of a predetermined dose over a sustained period have been used to overcome the shortcomings of conventional dosage forms. This is because the controlled drug delivery system can provide sustained therapeutic level of drug concentration without toxicity and convenience for patients. It would be more beneficial and ideal if the drug could be delivered by a device that would respond to external environmental change. Therefore, the correct amount of drug would be released upon the stimulation of such a temperature change. The purpose of study is synthesis of macroporous thermal responsive poly(HEMA-co-NIPAAM) hydrogels by free radical polymerization for controlled drug delivery applications. Effect of varying water and HEMA-NIPAAm ratio in the monomer mixture were resulted interconnected macroporous structure. From the result, 5HEMA15NIPAAm was showed the most rapid responsiveness in swelling ratio, polymer volume fraction, swelling and deswelling kinetics. The high drug loading capacity was achieved at or below ambient temperature, whilst the release profile was revealed sustain release of conventional anti-inflammatory drug; prednisolone 21 hemisuccinate sodium salt. In general, incorporating appropriate amount of water and HEMA-NIPAAm ratio can improve the swelling properties, drug loading capacity and drug release profile, which can be use for sustained release of various medication.
Key words: macroporous, thermosensitive hydrogel, controlled drug delivery application
Full Text:
PDF 250-257References
Chirila, T. V., Constable, I. J., Crawford, G. J., Vijayasekaran, S., Thompson, D. E., Chen, Y. C., Fletcher, and W. A., and Griffin, B., 1993, Poly(2-hydroxyethyl methacrylate) sponges as implant materials: in vivo and in vitro evaluation of cellular invasion. Biomaterials 14(1), 26-38.
Chirila, T. V., Hicks, C. R., Dalton, P. D., Vijayasekaran, S., Lou, X., Hong, Y., Clayton, A. B., Ziegelaar, B. W., Fitton, J. H., Platten, S., Crawford, G. J., and Constable, I. J., 1998, Artificial Cornea. Prog. Polym. Sci. 23, 447-473.
Crawford, G. J., Hicks, C. R., Lou, X., Vijayasekaran, S., Tan, D., Mulholland, B., Chirila, T. V., and Constable, I. J., 2002, The Chirila keratoprosthesis: phase I human clinical trial. Ophthalmology 109, 883-889.
Hicks, C. R., Morrison, D., Lou, X., Crawford, G. J., Gadjatsy, A., and Constable, I. J., 2006, Orbit implants: potential new directions. Expert Rev. Med. Devices 3, 805-815.
Hicks, C. R., Lou, X., Chirila, T. V., and Constable, I. J., 2002, WO. 02064071 A1 (2002), Lions Eye Institute Australia Inc.
Hoffman, A. S., 1987, Applications of thermally reversible polymers and hydrogels in therapeutics and diagnostics. J. Controlled Release 6, 297-305.
Li, X., Cui, Y., Lloyd, A. W., Mikhalovsky, S. V., Sandeman, S. R., Howel, C. A., and Liewen, L., 2008., Polymeric hydrogels for novel contact lens-based ophthalmic drug delivery systems: a review. Cont. Lens. Anterior. Eye 31(2), 57-64.
Lou, X., Munro, S., and Wang, S., 2004, Drug release characteristics of phase separation pHEMA sponge materials. Biomaterials 25, 5071-5080.
Lou, X., Vijayasekaran, S., Sugiharti, R., and Robertson, T., 2005, Morphological and topographic effects on calcification tendency of pHEMA hydrogels. Biomaterials 26, 5808-5817.
Lou, X., Wang, S., and Tan, S. Y., 2007, Mathematics-aided quantitative analysis of diffusion characteristics of pHEMA sponge hydrogels. Asia-Pac. J. Chem. Eng. 2, 609-617.
Okay, O., 2000, Macroporous copolymer network. Prog. Polym. Sci. 25, 711-779.
Oxley, H. R., Corkhill, P. H., Fitton, J. H., and Tighe, B. H., 1993, Macroporous hydrogels for biomedical applications: methodology and morphology. Biomaterials 14, 1064-1072.
Suzuki, A. and Tanaka, T., 1990, Phase transition in polymer gels induced by visible light. Nature 346, 345-347.
Zhang, X. Z., Xu, X. D., Cheng, S. X., and Zhuo, R. X., 2008, Strategies to improve response rate of thermosensitive PNIPAAm hydrogels. Soft Matter 4, 385-391.
DOI: http://dx.doi.org/10.14499/indonesianjpharm0iss0pp250-257
Refbacks
- There are currently no refbacks.
Copyright (c) 2017 INDONESIAN JOURNAL OF PHARMACY

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Indonesian J Pharm indexed by: